News Search Results
Jul 18, 2026, 14:55 ET REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
retinal laser; surgical treatment may be required for advanced PDR.2 ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jul 17, 2026, 10:15 ET Bioinformatics Market worth $34.41 billion by 2031 - Exclusive Report by MarketsandMarkets™
multi-omics data integration solutions.Pharmaceutical & biotechnology companies held largest share of bioinformatics market in 2025By end user, the bioinformatics market is divided into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinical
More news about: MarketsandMarkets
Jul 17, 2026, 07:00 ET REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
registration or qualification under the applicable securities laws of such state or jurisdiction.ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jul 17, 2026, 06:40 ET Medical Plastics Tubing Market worth $6.81 billion by 2031 - Exclusive Report by MarketsandMarkets™
and disposable as a measure to reduce the risk of infection. Both these aspects play a role in the overall market growth. The pharmaceutical and biotechnology industries are increasing their R&D activities and investments in advanced drug delivery technologies, which would further drive this segment.Inquiry
More news about: MarketsandMarkets
Jul 16, 2026, 23:48 ET HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
16 July 2026 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ; OTCQB: NUZTF) ("Neurizon" or "the Company"), a late-stage clinical biotechnology company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to advise that enrolment has been completed in Regimen
More news about: Neurizon Therapeutics Limited
Jul 16, 2026, 17:33 ET TRELLIS BIOSCIENCE RAISES $9 MILLION TO ADVANCE CLINICAL DEVELOPMENT OF CALPURBATUG (TRL1068)
REDWOOD CITY, Calif., July 16, 2026 /PRNewswire/ -- Trellis Bioscience, a clinical-stage biotechnology company developing native human monoclonal antibodies (mAbs) to treat intractable infectious diseases, today announced the closing of a $9 million
More news about: Trellis Bioscience Inc.
Jul 16, 2026, 16:26 ET REGENXBIO Announces Proposed Public Offering of Common Stock
registration or qualification under the applicable securities laws of such state or jurisdiction.ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jul 16, 2026, 14:30 ET Decisions CEO Giles Whiting Named to Inaugural Class of the Aspen Institute's Technology Leaders Initiative
decisions.Whiting is one of 22 senior leaders selected for the first cohort of the program, which brings together architects of artificial intelligence, biotechnology, quantum computing, energy infrastructure, and digital governance to examine the responsibilities that accompany rapid technological change."As
More news about: Decisions
Jul 16, 2026, 12:14 ET THE COSMETIC 360 TRADE SHOW UNVEILS THIS YEAR'S THEME: 'REGENERATIONS'
industry.CAPSULE D'ANTICIPATION - BIOTECHS 2045 BY GREENTECH, a pioneer and expert in biotechnology, will transport for the 2nd opus visitors into the future to reveal the role of biotechnology in cosmetics.THE INNOVATIVE TABLE par IBG x Centdegrés will bring together
More news about: COSMETIC 360
Jul 16, 2026, 12:11 ET THE COSMETIC 360 TRADE SHOW UNVEILS THIS YEAR'S THEME: 'REGENERATIONS'
industry.CAPSULE D'ANTICIPATION - BIOTECHS 2045 BY GREENTECH, a pioneer and expert in biotechnology, will transport for the 2nd opus visitors into the future to reveal the role of biotechnology in cosmetics.THE INNOVATIVE TABLE par IBG x Centdegrés will bring together
More news about: COSMETIC 360
Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™
Biotechnology Market Research Reports & ConsultingSee More Latest Biotechnology Reports:
More news about: MarketsandMarkets
Jul 16, 2026, 10:01 ET NASH Treatment Market Accelerates as Rezdiffra and Wegovy Establish Fibrosis-Defined Drug Pathways, Says Strategic Market Research
ResearchStrategic Market Research is a global market intelligence and consulting organization providing actionable insights across healthcare, pharmaceuticals, biotechnology, medical devices, technology, industrial, energy, consumer, and advanced manufacturing sectors.The company delivers data-driven market research,
More news about: Strategic Market Research LLP
Jul 16, 2026, 09:00 ET Frost & Sullivan Celebrates 65 Years of Transformational Growth with an Exclusive Executive Leadership Banquet
Avance Clinical2026 Global Biotechnology Contract Research Organization Company of the YearAvance Clinical accelerates biotechnology innovation by delivering specialized clinical research services that help bring new therapies
More news about: Frost & Sullivan
Jul 16, 2026, 09:00 ET Frost & Sullivan Celebrates 65 Years of Transformational Growth with an Exclusive Executive Leadership Banquet
Avance Clinical2026 Global Biotechnology Contract Research Organization Company of the YearAvance Clinical accelerates biotechnology innovation by delivering specialized clinical research services that help bring new therapies
More news about: Frost & Sullivan
Jul 16, 2026, 07:30 ET Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
LONDON, July 16, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), a biotechnology company focused on immune response detection, T cell immune profiling and in vitro diagnostic technologies, today published a shareholder update
More news about: Virax BioLabs Group Limited
Jul 16, 2026, 07:00 ET Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
complex therapies in emerging and underserved markets. By combining global coordination with local execution, FarmaMondo supports pharmaceutical and biotechnology companies in delivering treatments through structured and compliant pathways while actively managing the regulatory, pricing, market access, medical
More news about: ExCellThera
Jul 16, 2026, 07:00 ET Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
complex therapies in emerging and underserved markets. By combining global coordination with local execution, FarmaMondo supports pharmaceutical and biotechnology companies in delivering treatments through structured and compliant pathways while actively managing the regulatory, pricing, market access, medical
More news about: ExCellThera
Jul 16, 2026, 06:45 ET Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
financial advice to the AtaiBeckley Board of Directors in the transaction.About AtaiBeckleyAtaiBeckley is a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments. AtaiBeckley's pipeline
More news about: Eli Lilly and Company
Jul 16, 2026, 04:00 ET Slone Partners Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx
Prolynx, a biotechnology company developing a next-generation portfolio of ultra-long-acting medicines for obesity and related metabolic conditions.
More news about: Slone Partners
Jul 16, 2026, 02:55 ET GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering
transforming fields such as medicine, biotechnology and environmental sustainability, opening new possibilities for prevention, diagnosis and treatment."The microscopic world has a profound impact on our health, ecosystems and the future of biotechnology. The GIMM Festival aims to bring researchers
More news about: Fundação GIMM - Gulbenkian Institute for Molecular Medicine
Jul 15, 2026, 12:12 ET China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit
More news about: China Pharma Holdings, Inc.
Jul 15, 2026, 12:10 ET C-Path Names Karen Bernstein Board Chair and Welcomes Yalonda Howze and Milad Alucozai as Board Directors
of the Board of Overseers of Scripps Research and the Board of Mind What Matters, among other positions. Her honors include induction into the Biotechnology Hall of Fame, recognition by Scientific American as one of the 100 most influential people in biotech, and selection as one of the Silicon Valley
More news about: Critical Path Institute
Jul 15, 2026, 11:55 ET BIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience
neuromodulation technologies aimed at improving outcomes for patients with chronic pain. SNI also conducts and runs clinical trials and research in the biotechnology sector.About BIOTRONIK NeuroBIOTRONIK Neuro is a division of BIOTRONIK based in Lake Oswego, Oregon, focused on spinal cord
More news about: Soin Neuroscience
Jul 15, 2026, 11:46 ET BIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience
neuromodulation technologies aimed at improving outcomes for patients with chronic pain. SNI also conducts and runs clinical trials and research in the biotechnology sector.About BIOTRONIK NeuroBIOTRONIK Neuro is a division of BIOTRONIK based in Lake Oswego, Oregon, focused on spinal cord
More news about: Soin Neuroscience
Jul 15, 2026, 11:33 ET /C O R R E C T I O N -- Azitra, Inc./
biopharmaceutical company focused on developing innovative therapies for precision dermatology and novel products across therapeutics, cosmeceuticals and biotechnology applications. The Company's portfolio is highlighted by ATR-COSF, a recombinant protein technology designed for cosmetic and skincare applications,
More news about: Azitra, Inc.